TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Bio-Techne Corp (TECH)

Healthcare Biotechnology
72.10 $
+0.1% vs. previous close
Closing price · As of: 3. Aug 2026

Bio-Techne Corp (TECH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 2,551 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet TECH
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
2,639 2,755 2,731 2,721 2,704 2,736 2,670 2,644 2,558 2,526 2,523 2,551
621 591 591 611 617 649 635 627 608 610 637 688
181 149 130 140 152 188 178 141 162 145 173 210
204 149 136 145 153 188 178 141 162 145 173 210
218 205 207 228 241 224 218 237 207 184 185 218
172 186 181 179 180 185 188 191 189 203 205 201
226 – – – – – – – – – – –
873 969 980 971 973 983 965 969 981 979 981 978
535 579 551 526 507 486 461 444 366 350 335 319
672 758 767 707 635 597 592 626 639 560 512 465
129 128 135 150 159 142 161 169 176 145 140 153
11 12 13 13 13 13 14 14 14 14 14 14
26 28 32 29 38 32 33 32 25 30 26 23
350 440 447 389 319 300 300 330 346 300 260 200
1,967 1,998 1,964 2,014 2,069 2,139 2,078 2,018 1,919 1,966 2,011 2,085
1,309 1,328 1,261 1,298 1,325 1,341 1,287 1,196 1,066 1,083 1,107 1,145
162 162 160 160 161 161 161 159 156 156 157 157

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?